Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers
Article in Supportive Care in Cancer (January 2022)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Review of Bone Modifying Agents in Metastatic Breast Cancer
Article in Cureus (February 2021)
The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico
Article in Journal of Medical Economics (January 2021)